Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AdaptHealth (AHCO) Short term Debt (2018 - 2025)

AdaptHealth has reported Short term Debt over the past 8 years, most recently at $20.3 million for Q4 2025.

  • Quarterly results put Short term Debt at $20.3 million for Q4 2025, up 25.0% from a year ago — trailing twelve months through Dec 2025 was $20.3 million (up 25.0% YoY), and the annual figure for FY2025 was $20.3 million, up 25.0%.
  • Short term Debt for Q4 2025 was $20.3 million at AdaptHealth, up from $16.2 million in the prior quarter.
  • Over the last five years, Short term Debt for AHCO hit a ceiling of $96.8 million in Q2 2021 and a floor of $16.2 million in Q3 2024.
  • Median Short term Debt over the past 5 years was $22.7 million (2022), compared with a mean of $31.0 million.
  • Biggest five-year swings in Short term Debt: surged 3644.2% in 2021 and later plummeted 74.16% in 2022.
  • AdaptHealth's Short term Debt stood at $20.0 million in 2021, then soared by 75.0% to $35.0 million in 2022, then skyrocketed by 52.48% to $53.4 million in 2023, then crashed by 69.55% to $16.2 million in 2024, then increased by 25.0% to $20.3 million in 2025.
  • The last three reported values for Short term Debt were $20.3 million (Q4 2025), $16.2 million (Q3 2025), and $16.2 million (Q2 2025) per Business Quant data.